$CBGL
CANNABIS GLOBAL, INC. Stock $cbgl

$cbgl Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000107997322000868 Filed on July 20, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue		$792.4K	$627.4K
YoY Change		-15.75%	2329.86%
Cost Of Revenue		$780.8K	$767.9K
YoY Change		7.02%	11447.37%
Gross Profit		$11.63K	-$140.5K
YoY Change		-94.49%	-832.97%
Gross Profit Margin		1.47%	-22.4%
Selling, General & Admin		$354.8K	$938.2K
YoY Change		-49.81%	117.4%
% of Gross Profit		3051.43%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$185.0K	$826.5K
YoY Change		20455.56%	45814.44%
% of Gross Profit		1590.99%
Operating Expenses		$354.8K	$938.2K
YoY Change		-49.81%	117.4%
Operating Profit		-$343.2K	-$1.079M
YoY Change		-30.81%	161.57%
Interest Expense		-$162.7K	$151.8K
YoY Change		-92.67%	-108.93%
% of Operating Profit
Other Income/Expense, Net		-$162.7K	$289.8K
YoY Change		-92.67%	18963.82%
Pretax Income		-$505.9K	-$697.1K
YoY Change		-81.37%	-66.97%
Income Tax
% Of Pretax Income
Net Earnings		-$505.9K	-$697.1K
YoY Change		-81.37%	-66.97%
Net Earnings / Revenue		-63.85%	-111.12%
Basic Earnings Per Share		$0.00
Diluted Earnings Per Share		$0.00	-$1.857K
COMMON SHARES
Basic Shares Outstanding	568.2M shares	516.7M shares
Diluted Shares Outstanding		516.7M shares

Balance Sheet

Concept	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$253.4K	$604.0K
YoY Change	-5.46%	350.11%
Cash & Equivalents	$253.4K
Short-Term Investments
Other Short-Term Assets	$20.19K	$10.50K
YoY Change
Inventory	$197.6K	$195.6K
Prepaid Expenses	$400.0K
Receivables	$405.1K	$472.6K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$1.297M	$1.283M
YoY Change	42.58%	96.13%
LONG-TERM ASSETS
Property, Plant & Equipment	$997.1K	$1.615M
YoY Change	-51.14%	-17.98%
Goodwill	$7.925M
YoY Change
Intangibles
YoY Change
Long-Term Investments	$357.0K	$407.0K
YoY Change	-45.08%	-37.38%
Other Assets	$7.200K	$7.200K
YoY Change	0.0%	0.0%
Total Long-Term Assets	$13.61M	$13.87M
YoY Change	20.06%	23.07%
TOTAL ASSETS
Total Short-Term Assets	$1.297M	$1.283M
Total Long-Term Assets	$13.61M	$13.87M
Total Assets	$14.91M	$15.15M
YoY Change	21.73%	27.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$721.2K	$747.0K
YoY Change	13.46%	60.86%
Accrued Expenses	$185.9K	$222.5K
YoY Change	-31.62%	10.45%
Deferred Revenue
YoY Change
Short-Term Debt	$2.193M	$1.987M
YoY Change	27.72%	-22.54%
Long-Term Debt Due	$787.3K	$890.4K
YoY Change	-20.88%	-47.62%
Total Short-Term Liabilities	$6.114M	$6.693M
YoY Change	-24.77%	-5.94%
LONG-TERM LIABILITIES
Long-Term Debt	$669.2K	$0.00
YoY Change
Other Long-Term Liabilities	$504.3K	$524.4K
YoY Change	-7.51%	-3.83%
Total Long-Term Liabilities	$1.174M	$524.4K
YoY Change	115.23%	-3.83%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.114M	$6.693M
Total Long-Term Liabilities	$1.174M	$524.4K
Total Liabilities	$7.287M	$11.66M
YoY Change	-42.22%	1.27%
SHAREHOLDERS EQUITY
Retained Earnings	-$14.49M
YoY Change
Common Stock	$553.1K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.213M	$3.492M
YoY Change
Total Liabilities & Shareholders Equity	$14.91M	$15.15M
YoY Change	21.73%	27.08%

Cashflow Statement

Concept	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$505.9K	-$697.1K
YoY Change	-81.37%	-66.97%
Depreciation, Depletion And Amortization	$185.0K	$826.5K
YoY Change	20455.56%	45814.44%
Cash From Operating Activities	-$238.4K	-$337.5K
YoY Change	-42.08%	-56.42%
INVESTING ACTIVITIES
Capital Expenditures	$980.00	-$6.400K
YoY Change	-110.3%
Acquisitions
YoY Change
Other Investing Activities	$42.77K	$189.1K
YoY Change		8495.0%
Cash From Investing Activities	$43.74K	$182.7K
YoY Change	-559.94%	8204.09%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-156.0K	669.9K
YoY Change	-128.1%	-25.91%
NET CHANGE
Cash From Operating Activities	-238.4K	-337.5K
Cash From Investing Activities	43.74K	182.7K
Cash From Financing Activities	-156.0K	669.9K
Net Change In Cash	-350.6K	515.1K
YoY Change	-362.02%	290.64%
FREE CASH FLOW
Cash From Operating Activities	-$238.4K	-$337.5K
Capital Expenditures	$980.00	-$6.400K
Free Cash Flow	-$239.4K	-$331.1K
YoY Change	-40.47%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	113379	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	400000	usd
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	197602	usd
	dei	Entity Shell Company EntityShellCompany	false
CY2021Q3	us-gaap	Inventory Net InventoryNet	189081	usd
CY2022Q2	us-gaap	Other Assets Current OtherAssetsCurrent	20185	usd
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	568208573	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	253368	usd
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	30813	usd
CY2021Q3	us-gaap	Other Assets Current OtherAssetsCurrent	7992	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	405121	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Ste. 320
	dei	Entity Address City Or Town EntityAddressCityOrTown	Los Angeles
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90071
CY2022Q2	us-gaap	Assets Current AssetsCurrent	1297276	usd
CY2021Q3	us-gaap	Assets Current AssetsCurrent	442065	usd
	dei	City Area Code CityAreaCode	(310)
	dei	Local Phone Number LocalPhoneNumber	986-4929
	dei	Security12b Title Security12bTitle	Common
	dei	Trading Symbol TradingSymbol	CBGL
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Central Index Key EntityCentralIndexKey	0001413488
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--08-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2020Q4	cbgl	Proceeds From Common Stock Subscriptions Value ProceedsFromCommonStockSubscriptionsValue		usd
CY2020Q4	cbgl	Effects Of Par Value Adjustment EffectsOfParValueAdjustment		usd
CY2022Q1	cbgl	Common Stock Issued In Exchange For Exercise Of Warrants On Cashless Basis CommonStockIssuedInExchangeForExerciseOfWarrantsOnCashlessBasis		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-05-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-27039
	dei	Entity Registrant Name EntityRegistrantName	CANNABIS GLOBAL, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	83-1754057
	dei	Entity Address Address Line1 EntityAddressAddressLine1	520 S. Grand Avenue
CY2021Q3	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	734579	usd
CY2022Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	945549	usd
CY2021Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1206708	usd
CY2022Q2	cbgl	Convertible Notes Related Party Debt Discount Current ConvertibleNotesRelatedPartyDebtDiscountCurrent	13260	usd
CY2021Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	0	usd
CY2022Q2	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	21000	usd
CY2021Q3	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	100800	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	997064	usd
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	218535	usd
CY2022Q2	us-gaap	Long Term Investments LongTermInvestments	357000	usd
CY2021Q3	us-gaap	Long Term Investments LongTermInvestments	650000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3702500	usd
CY2021Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	500000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	581611	usd
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	634637	usd
CY2022Q2	us-gaap	Goodwill Goodwill	7925000	usd
CY2021Q3	us-gaap	Goodwill Goodwill	8842967	usd
CY2022Q2	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	41000	usd
CY2021Q3	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	41000	usd
CY2022Q2	us-gaap	Security Deposit SecurityDeposit	7200	usd
CY2021Q3	us-gaap	Security Deposit SecurityDeposit	9600	usd
CY2022Q2	us-gaap	Assets Assets	14908651	usd
CY2021Q3	us-gaap	Assets Assets	11338804	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	721156	usd
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	730825	usd
CY2022Q2	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	2639	usd
CY2021Q3	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	2639	usd
CY2022Q2	us-gaap	Interest Payable Current InterestPayableCurrent	108615	usd
CY2021Q3	us-gaap	Interest Payable Current InterestPayableCurrent	212202	usd
CY2022Q2	cbgl	Due To Joint Venture DueToJointVenture	0	usd
CY2021Q3	cbgl	Due To Joint Venture DueToJointVenture	135000	usd
CY2022Q2	us-gaap	Notes Payable Current NotesPayableCurrent	787302	usd
CY2021Q3	us-gaap	Notes Payable Current NotesPayableCurrent	975043	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	77318	usd
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	71754	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	1191951	usd
CY2021Q3	cbgl	Convertible Notes Related Party Debt Discount Current ConvertibleNotesRelatedPartyDebtDiscountCurrent	721393	usd
CY2022Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	1139636	usd
CY2021Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	408607	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-2212343	usd
CY2022Q2	cbgl	Series B Convertible Preferred Stock SeriesBConvertiblePreferredStock	63557	usd
CY2021Q3	cbgl	Series B Convertible Preferred Stock SeriesBConvertiblePreferredStock	148775	usd
CY2022Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	2160048	usd
CY2021Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	4747614	usd
CY2022Q2	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	108039	usd
CY2021Q3	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	108039	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	6113859	usd
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	8747206	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	504293	usd
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	562997	usd
CY2022Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	669237	usd
CY2021Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	672794	usd
CY2022Q2	us-gaap	Liabilities Liabilities	7287389	usd
CY2021Q3	us-gaap	Liabilities Liabilities	9982997	usd
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	6000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	6000000	shares
CY2021Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	6000000	shares
CY2021Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	6000000	shares
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	600	usd
CY2021Q3	us-gaap	Preferred Stock Value PreferredStockValue	600	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4000000000	shares
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4000000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	553142691	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	553142691	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	84940028	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	84940028	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	553141	usd
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	84938	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	17147346	usd
CY2021Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	11591829	usd
CY2022Q2	cbgl	Shares To Be Issued SharesToBeIssued	2078	usd
CY2021Q3	cbgl	Shares To Be Issued SharesToBeIssued	2078	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-14490085	usd
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13891788	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	3213080	usd
CY2022Q2	us-gaap	Minority Interest MinorityInterest	4408182	usd
CY2021Q3	us-gaap	Minority Interest MinorityInterest	3568150	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7621262	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1355807	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14908651	usd
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11338804	usd
CY2022Q2	us-gaap	Revenues Revenues	792406	usd
CY2021Q2	us-gaap	Revenues Revenues	940491	usd
	us-gaap	Revenues Revenues	1989358	usd
	us-gaap	Revenues Revenues	970717	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	780778	usd
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	729589	usd
	us-gaap	Cost Of Revenue CostOfRevenue	2004642	usd
	us-gaap	Cost Of Revenue CostOfRevenue	737542	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	11628	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	210902	usd
	us-gaap	Gross Profit GrossProfit	-15284	usd
	us-gaap	Gross Profit GrossProfit	233175	usd
CY2022Q2	cbgl	Advertising Expenses AdvertisingExpenses	25671	usd
CY2021Q2	cbgl	Advertising Expenses AdvertisingExpenses	16234	usd
	cbgl	Advertising Expenses AdvertisingExpenses	49634	usd
	cbgl	Advertising Expenses AdvertisingExpenses	66758	usd
CY2022Q2	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	56585	usd
CY2021Q2	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	34500	usd
	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	63085	usd
	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	286551	usd
CY2022Q2	us-gaap	Professional Fees ProfessionalFees	19796	usd
CY2021Q2	us-gaap	Professional Fees ProfessionalFees	235521	usd
	us-gaap	Professional Fees ProfessionalFees	290870	usd
	us-gaap	Professional Fees ProfessionalFees	415416	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	252764	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	420649	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1224291	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	817141	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	354816	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	706904	usd
	us-gaap	Operating Expenses OperatingExpenses	1627880	usd
	us-gaap	Operating Expenses OperatingExpenses	1585866	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-343188	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-496002	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1643164	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1352691	usd
CY2022Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	301220	usd
CY2021Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	3630290	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	4044453	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	6336773	usd
CY2022Q2	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	145714	usd
CY2021Q2	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	1410329	usd
	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	3634274	usd
	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	2719241	usd
CY2022Q2	us-gaap	Other Income OtherIncome	0	usd
CY2021Q2	us-gaap	Other Income OtherIncome	0	usd
	us-gaap	Other Income OtherIncome	0	usd
	us-gaap	Other Income OtherIncome	1642	usd
CY2022Q2	cbgl	Gain Loss On Impairment GainLossOnImpairment	0	usd
CY2021Q2	cbgl	Gain Loss On Impairment GainLossOnImpairment	0	usd
	cbgl	Gain Loss On Impairment GainLossOnImpairment	-60000	usd
	cbgl	Gain Loss On Impairment GainLossOnImpairment	0	usd
CY2022Q2	cbgl	Gain Loss On Settlement GainLossOnSettlement	0	usd
CY2021Q2	cbgl	Gain Loss On Settlement GainLossOnSettlement	0	usd
	cbgl	Gain Loss On Settlement GainLossOnSettlement	-165000	usd
	cbgl	Gain Loss On Settlement GainLossOnSettlement	0	usd
CY2022Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	-7231	usd
CY2021Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	53736	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	usd
CY2022Q2	cbgl	Gain Loss On Acquisition GainLossOnAcquisition	0	usd
CY2021Q2	cbgl	Gain Loss On Acquisition GainLossOnAcquisition	0	usd
	cbgl	Gain Loss On Acquisition GainLossOnAcquisition	454768	usd
	cbgl	Gain Loss On Acquisition GainLossOnAcquisition	0	usd
CY2022Q2	us-gaap	Oci Equity Method Investment Tax OciEquityMethodInvestmentTax	-0	usd
CY2021Q2	us-gaap	Oci Equity Method Investment Tax OciEquityMethodInvestmentTax	-0	usd
	us-gaap	Oci Equity Method Investment Tax OciEquityMethodInvestmentTax	-934867	usd
	us-gaap	Oci Equity Method Investment Tax OciEquityMethodInvestmentTax	211376	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-162737	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2219961	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	808192	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3827266	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-505925	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-2715963	usd
	us-gaap	Net Income Loss NetIncomeLoss	-834972	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5179957	usd
CY2022Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-31347	usd
CY2021Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	92318	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-236675	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	92318	usd
CY2022Q2	cbgl	Net Income Loss Attributable To Cannabis Global Inc. NetIncomeLossAttributableToCannabisGlobalInc.	-474578	usd
CY2021Q2	cbgl	Net Income Loss Attributable To Cannabis Global Inc. NetIncomeLossAttributableToCannabisGlobalInc.	-2808281	usd
	cbgl	Net Income Loss Attributable To Cannabis Global Inc. NetIncomeLossAttributableToCannabisGlobalInc.	-598297	usd
	cbgl	Net Income Loss Attributable To Cannabis Global Inc. NetIncomeLossAttributableToCannabisGlobalInc.	-5272275	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	516732435	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	68325203	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	333686021	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49661819	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	516732435	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	68325203	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	333686021	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49661819	shares
CY2020Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1435286	usd
CY2020Q4	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	183000	usd
CY2020Q4	cbgl	Common Stock Issued For Investment Value CommonStockIssuedForInvestmentValue	650000	usd
CY2020Q4	cbgl	Common Stock Issued In Settlement Of Convertible Notes Payable And Accrued Interest Value CommonStockIssuedInSettlementOfConvertibleNotesPayableAndAccruedInterestValue	30000	usd
CY2020Q4	us-gaap	Profit Loss ProfitLoss	-353224	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-925510	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	339334	usd
CY2021Q1	cbgl	Proceeds From Common Stock Subscriptions Value ProceedsFromCommonStockSubscriptionsValue	391000	usd
CY2021Q1	cbgl	Common Stock Issued For Investment Value CommonStockIssuedForInvestmentValue	6071468	usd
CY2021Q1	cbgl	Common Stock Issued In Settlement Of Convertible Notes Payable And Accrued Interest Value CommonStockIssuedInSettlementOfConvertibleNotesPayableAndAccruedInterestValue	216729	usd
CY2021Q1	cbgl	Derivative Impact Of Conversions DerivativeImpactOfConversions	276975	usd
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-2110770	usd
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4259226	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	71433	usd
CY2021Q2	cbgl	Proceeds From Common Stock Subscriptions Value ProceedsFromCommonStockSubscriptionsValue	78851	usd
CY2021Q2	cbgl	Common Stock Issued In Settlement Of Convertible Notes Payable And Accrued Interest Value CommonStockIssuedInSettlementOfConvertibleNotesPayableAndAccruedInterestValue	668250	usd
CY2021Q2	cbgl	Derivative Impact Of Conversions DerivativeImpactOfConversions	1213985	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-2715968	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3575782	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1355807	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	89374	usd
CY2021Q4	cbgl	Common Stock Issued In Settlement Of Convertible Notes Payable And Accrued Interest Value CommonStockIssuedInSettlementOfConvertibleNotesPayableAndAccruedInterestValue	1057742	usd
CY2021Q4	cbgl	Derivative Impact Of Conversions DerivativeImpactOfConversions	1273832	usd
CY2021Q4	us-gaap	Profit Loss ProfitLoss	368078	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4144833	usd
CY2022Q1	cbgl	Common Stock Issued In Settlement Of Convertible Notes Payable And Accrued Interest Value CommonStockIssuedInSettlementOfConvertibleNotesPayableAndAccruedInterestValue	567059	usd
CY2022Q1	cbgl	Common Stocks Issued Related To Joint Venture CommonStocksIssuedRelatedToJointVenture	300000	usd
CY2022Q1	cbgl	Discounts On Convertible Notes DiscountsOnConvertibleNotes	25200	usd
CY2022Q1	cbgl	Derivative Impact Of Conversions DerivativeImpactOfConversions	785109	usd
CY2022Q1	cbgl	Acquisition Measurements Period Adjustment AcquisitionMeasurementsPeriodAdjustment	2805960	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-697125	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7931036	usd
CY2022Q2	cbgl	Common Stock Issued In Settlement Of Convertible Notes Payable And Accrued Interest Value CommonStockIssuedInSettlementOfConvertibleNotesPayableAndAccruedInterestValue	101260	usd
CY2022Q2	cbgl	Derivative Impact Of Conversions DerivativeImpactOfConversions	94891	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-505925	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7621262	usd
	us-gaap	Net Income Loss NetIncomeLoss	-834972	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5179957	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	3691626	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	5784092	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	53736	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-0	usd
	cbgl	Joint Venture Settlement JointVentureSettlement	165000	usd
	cbgl	Joint Venture Settlement JointVentureSettlement	0	usd
	cbgl	Gain Loss On Acquisitions GainLossOnAcquisitions	-60000	usd
	cbgl	Gain Loss On Acquisitions GainLossOnAcquisitions	-0	usd
	cbgl	Gain On Acquisition Accounting GainOnAcquisitionAccounting	454768	usd
	cbgl	Gain On Acquisition Accounting GainOnAcquisitionAccounting	-0	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-934868	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	211376	usd
	us-gaap	Depreciation Depreciation	1077958	usd
	us-gaap	Depreciation Depreciation	2697	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	89374	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	593767	usd
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-3634274	usd
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-2719241	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	53026	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	0	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-291742	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-165206	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	12193	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-0	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	163979	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-106930	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	82200	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	20447	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	42655	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	37570	usd
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	0	usd
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	9998	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	151736	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	190300	usd
	cbgl	Right Of Use Lease Liability RightOfUseLeaseLiability	53140	usd
	cbgl	Right Of Use Lease Liability RightOfUseLeaseLiability	-0	usd
	cbgl	Increase Decrease In Due To Joint Venture IncreaseDecreaseInDueToJointVenture	0	usd
	cbgl	Increase Decrease In Due To Joint Venture IncreaseDecreaseInDueToJointVenture	135000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-692139	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1186087	usd
	cbgl	Cash Acquired In Acquisition CashAcquiredInAcquisition	0	usd
	cbgl	Cash Acquired In Acquisition CashAcquiredInAcquisition	2200	usd
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	5424	usd
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	9511	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	346736	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	341312	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7311	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1288620	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1891000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	469851	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	351440	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	854500	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	59013	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-422811	usd
	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-47284	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	573382	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1459067	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	222555	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	265669	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	30813	usd
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2338	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	253368	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	268007	usd
	us-gaap	Interest Paid Net InterestPaidNet	173548	usd
	us-gaap	Interest Paid Net InterestPaidNet	301135	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
	cbgl	Shares Issued And Loan Incurred For Acquisition Of Intangible Assets SharesIssuedAndLoanIncurredForAcquisitionOfIntangibleAssets	0	usd
	cbgl	Shares Issued And Loan Incurred For Acquisition Of Intangible Assets SharesIssuedAndLoanIncurredForAcquisitionOfIntangibleAssets	650000	usd
	cbgl	Inventory Acquired With Short Term Note Payable InventoryAcquiredWithShortTermNotePayable	172500	usd
	cbgl	Inventory Acquired With Short Term Note Payable InventoryAcquiredWithShortTermNotePayable	0	usd
	cbgl	Shares Issued For Conversion Of Notes Payable And Accrued Interest SharesIssuedForConversionOfNotesPayableAndAccruedInterest	1357742	usd
	cbgl	Shares Issued For Conversion Of Notes Payable And Accrued Interest SharesIssuedForConversionOfNotesPayableAndAccruedInterest	914979	usd
	cbgl	Common Stock Issued For Acquisition Of Npe CommonStockIssuedForAcquisitionOfNpe	0	usd
	cbgl	Common Stock Issued For Acquisition Of Npe CommonStockIssuedForAcquisitionOfNpe	2872175	usd
	cbgl	Increase In Noncontrolling Interest From Acquisition Of Npe IncreaseInNoncontrollingInterestFromAcquisitionOfNpe	0	usd
	cbgl	Increase In Noncontrolling Interest From Acquisition Of Npe IncreaseInNoncontrollingInterestFromAcquisitionOfNpe	3849293	usd
	cbgl	Common Stock Issued Related To Joint Venture CommonStockIssuedRelatedToJointVenture	300000	usd
	cbgl	Common Stock Issued Related To Joint Venture CommonStockIssuedRelatedToJointVenture	0	usd
	cbgl	Discount On Convertible Notes DiscountOnConvertibleNotes	25200	usd
	cbgl	Discount On Convertible Notes DiscountOnConvertibleNotes	0	usd
	cbgl	Acquisition Measurement Period Adjustment AcquisitionMeasurementPeriodAdjustment	2805960	usd
	cbgl	Acquisition Measurement Period Adjustment AcquisitionMeasurementPeriodAdjustment	0	usd
	cbgl	Convertible Note Payable Issued For Prepaid Expense ConvertibleNotePayableIssuedForPrepaidExpense	400000	usd
	cbgl	Convertible Note Payable Issued For Prepaid Expense ConvertibleNotePayableIssuedForPrepaidExpense	0	usd
	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	293000000	shares
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	346736	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	53736	usd
CY2020Q4	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	3000000	shares
CY2020Q4	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	177000	usd
	cbgl	Acquisition Of Natural Plant Extract Of California Inc AcquisitionOfNaturalPlantExtractOfCaliforniaInc	<p id="xdx_80E_ecustom--AcquisitionOfNaturalPlantExtractOfCaliforniaInc_zu5A5o9Buoka" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 6. <span id="xdx_829_zsJDf95Ep81k">Acquisition of Natural Plant Extract of California, Inc.</span></b></p> <p style="font: 10pt/11.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt/11.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 31, 2020 we issued a convertible promissory note pursuant to a Stock Purchase Agreement (the “SPA) with Robert L. Hymers, III (“Hymers”) to acquire <span id="xdx_901_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20200801__20200831__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_pdd" title="Shares issued for business acquisition">266,667</span> shares of common stock of Natural Plant Extract of California Inc., a California corporation (“NPE”), representing 18.8% of the outstanding capital stock of NPE on a fully diluted basis. With the exception of the entry into the subject material definitive agreements, no material relationship exists between us, or any of our affiliates or control persons and Hymers. Under the terms of the SPA, we acquired all rights and responsibilities of the equity stake for a purchase price of Two Million Forty Thousand United States Dollars ($2,040,000) (the “Purchase Price”). Relative to the payment of the Purchase Price, we agreed to: 1) pay Hymers twenty thousand dollars ($20,000) each month for a period of twenty-seven (27) months, with the first payment commencing September 1, 2020 and the remaining payments due and payable on the first day of each subsequent month until Hymers has received Five Hundred Forty Thousand United Stated Dollars ($540,000), and 2) issue Hymers a convertible promissory note in the amount of One Million Five Hundred Thousand United States Dollars ($1,500,000) (the “Note”). The Note bears interest at ten percent (10%) per annum. Hymers has the right at any time six (6) months after the issuance date to convert all or any part of the outstanding and unpaid principal, interest, fees, or any other obligation owed pursuant to the note. Conversion Price shall be calculated as follows: 60% of the lowest Trading Price of the common shares during the ten (10) days preceding the date the Company receive a notice of conversion. Unless permitted by the applicable rules and regulations of the principal securities market on which the common stock is then listed or traded, in no event shall we issue upon conversion of or otherwise pursuant to the note and the other notes issued, more than the maximum number of shares of common stock that we can issue pursuant to any rule of the principal United States securities market on which the common stock is then traded, which shall be <span id="xdx_904_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20200821__us-gaap--BusinessAcquisitionAxis__custom--NPEMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zXwyox7xna59" title="Ownership percentage">4.99</span>% of the total shares outstanding at any time. A debt discount of $54,212 on the note payable at issuance was calculated based on the present value of the note using an implied interest rate of <span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentRate_dp_c20210801__20210831_zbWm7JdLI9g4" title="Interest rate">10</span>%. A debt discount of $<span id="xdx_90B_eus-gaap--DebtInstrumentUnamortizedDiscount_c20200821__us-gaap--BusinessAcquisitionAxis__custom--NPEMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_pp0p0" title="Debt discount">270,886</span> was recognized. Accordingly, we recorded an initial value of its investment in NPE of $<span id="xdx_909_eus-gaap--Investments_c20200821__us-gaap--BusinessAcquisitionAxis__custom--NPEMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_pp0p0" title="Initial investment">1,714,903</span>. </p> <p style="font: 10pt/11.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt/11.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 11, 2021, we amended the material definitive agreement with Hymers. The amendment relieved us from having to make monthly payments of $20,000 to Hymers in exchange for our issuing a convertible promissory note to Hymers for the balance owed of $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_c20210611_pp0p0" title="Principal amount">440,000</span>.</p> <p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0 0 0 0.5in"> </p> <p style="font: 10pt/11.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 27, 2021, the Company acquired an additional 18.8% interest in NPE from Edward Manolos, a Director of the Company and a related party. The Company issued 11,383,929 shares of common stock, which had a fair value of $<span id="xdx_905_ecustom--AdditionalFairValue_pp0p0_c20210101__20210127__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrManolosMember_zBjOYSkcfUw2" title="Additional fair value">1,821,429</span>.</p> <p style="font: 10pt/105% Cambria, Times, Serif; margin: 0"> </p> <p style="font: 10pt/11.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 16, 2021, we purchased <span id="xdx_90F_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20210201__20210216__us-gaap--BusinessAcquisitionAxis__custom--NPEMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zy4hAmCL3wgf" title="Shares issued for business acquisition">266,667</span> shares of common stock of NPE from Alan Tsai, in exchange for the issuance of <span id="xdx_90F_ecustom--AdditionalSharesIssuedToRelatedParties_c20210201__20210216__us-gaap--BusinessAcquisitionAxis__custom--NPEMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zWeFTXNaLuM1" title="Additional shares issued to related parties">1,436,368</span> common shares of the Company. Other than with respect to the transaction, there was no material relationship between Mr. Tsai and us. By virtue of the transaction, we acquired 18.8% of the outstanding capital stock of NPE, bringing our total beneficial ownership in NPE to 56.5%. The transfer of control constituted an acquisition of NPE by the Company (the “NPE Acquisition”). For the three month period following the one year anniversary of the closing date, Mr. Tsai has the sole and irrevocable option to require the Company to repurchase the common shares issued to Mr. Tsai. If the value of the shares at the time notice is given is less than $150,000, Mr. Tsai will receive $150,000. If the value of the shares at the time notices is given is greater than $150,000, then Mr. Tsai will receive the market value of the shares.</p> <p style="font: 10pt/105% Cambria, Times, Serif; margin: 0"> </p> <p style="font: 10pt/11.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As a result of the transaction, we became party to a Shareholder Agreement with respect to our ownership over the NPE Shares, dated June 5, 2020, by and among Alan Tsai, Robert Hymers III, Betterworld Ventures, LLC (“BWV”), Marijuana Company of America, Inc. and NPE. The Joinder Agreement contains terms and conditions including, but not limited to: the ownership and management of NPE, rights of shareholders concerning the transfer of shares in NPE, pre-emptive rights, drag-along rights, confidentiality, and term and termination.</p> <p style="font: 10pt/105% Cambria, Times, Serif; margin: 0"> </p> <p style="font: 10pt/11.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The NPE acquisition is being accounted for as a business combination under ASC 805 as a result of the transfer of control.</p> <p style="font: 10pt/105% Cambria, Times, Serif; margin: 0"> </p> <p style="font: 10pt/11.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following information summarizes the purchase consideration and allocation of the fair values assigned to the assets at the purchase date:</p> <p style="font: 10pt/11.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_881_ecustom--ScheduleOfPreliminaryPurchasePriceAllocation_zxdCqlVwl0ij" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Acquisition of Natural Plant Extract of California, Inc. (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"><span id="xdx_8BD_znim962Z69uc" style="display: none">Schedule of Preliminary Purchase Price Allocation</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_493_20210216_us-gaap--BusinessAcquisitionAxis_custom--NPEMember" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif">Purchase Price Allocation:</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 70%; padding-left: 9pt">Cash</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">2,200</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt">Accounts receivable</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">193,607</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsNotesReceivable_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt">Notes receivable</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">162,247</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt">Property and equipment</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,153,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLease_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt">Right of use asset – operating lease</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">673,425</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt">Trademarks and trade names, estimated 5 year life</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">300,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_403_ecustom--BusinessCombinationRecognizedIdentifiableLicenses_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt">Licenses, estimated 10 year life</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,500,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--BusinessCombinationRecognizedCustomerRelationships_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt">Customer relationships, estimated 5 year life</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,300,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--Goodwill_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 9pt">Goodwill</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">7,925,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 9pt">Total assets acquired</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">14,209,479</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt">Accounts payable and accrued expenses</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">289,591</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_407_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesRightOfUseLiabilityOperatingLease_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt">Right of use liability – operating lease</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">673,425</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_402_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayable_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt">Notes payable</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,825,101</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_409_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedParty_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 9pt">Notes payable – related party</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">105,539</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total Liabilities Assumed</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">2,893,656</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt/11.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Immediately prior to obtaining control, our total investment in NPE was adjusted to the preliminary fair value of $<span id="xdx_900_eus-gaap--AssetsFairValueAdjustment_c20210201__20210216__us-gaap--BusinessAcquisitionAxis__custom--NPEMember_pp0p0" title="Fair value adjustment">3,324,956</span>, resulting in a loss on investment of $<span id="xdx_907_eus-gaap--GainLossOnInvestments_c20210201__20210216__us-gaap--BusinessAcquisitionAxis__custom--NPEMember_pp0p0" title="Gain loss on investment">359,391</span> booked during the year ended August 31, 2021. As the Company completed its assessment of the fair value of assets assumed and liabilities incurred, the Company recognized equity income of $<span id="xdx_909_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_c20220531_pp0p0" title="Fair value of assets and liabilities">934,868</span> during the nine months ended May 31, 2022, to arrive at a total initial non-controlling interest balance of $<span id="xdx_90F_eus-gaap--NoncontrollingInterestIncreaseFromBusinessCombination_c20210901__20220531_pp0p0" title="Non-controlling interest">4,926,000</span> as of the acquisition date. The Company also adjusted the previously recognized loss on business of $<span id="xdx_90B_eus-gaap--BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_c20210216__us-gaap--BusinessAcquisitionAxis__custom--NPEMember_pp0p0" title="Non-controlling interest">454,768</span> based on the final fair value adjustments.</p> <p style="font: 10pt/11.5pt Cambria, Times, Serif; margin: 0; text-align: justify"> </p>
CY2021Q3	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0.10	pure
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-14490085	usd
	us-gaap	Net Income Loss NetIncomeLoss	-834972	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-692139	usd
CY2022Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0	usd
CY2021Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0	usd
CY2022Q2	us-gaap	Deposit Assets DepositAssets	0	usd
CY2019Q2	us-gaap	Notes Payable Current NotesPayableCurrent	16667	usd
CY2019Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.05	pure
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2021Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2020Q4	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	3000000	shares
	us-gaap	Share Based Compensation ShareBasedCompensation	89374	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	593767	usd
CY2021Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	440000	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	934868	usd
	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	4926000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4540000	usd
CY2021Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	500000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	837500	usd
CY2021Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-0	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3702500	usd
CY2021Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	500000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	837500	usd
CY2022Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	100000	usd
CY2022Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	3000000	shares
	cbgl	Schedule Of Preliminary Purchase Price Allocation ScheduleOfPreliminaryPurchasePriceAllocation	<table cellpadding="0" cellspacing="0" id="xdx_881_ecustom--ScheduleOfPreliminaryPurchasePriceAllocation_zxdCqlVwl0ij" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Acquisition of Natural Plant Extract of California, Inc. (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"><span id="xdx_8BD_znim962Z69uc" style="display: none">Schedule of Preliminary Purchase Price Allocation</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_493_20210216_us-gaap--BusinessAcquisitionAxis_custom--NPEMember" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif">Purchase Price Allocation:</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 70%; padding-left: 9pt">Cash</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">2,200</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt">Accounts receivable</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">193,607</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsNotesReceivable_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt">Notes receivable</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">162,247</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt">Property and equipment</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,153,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLease_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt">Right of use asset – operating lease</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">673,425</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt">Trademarks and trade names, estimated 5 year life</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">300,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_403_ecustom--BusinessCombinationRecognizedIdentifiableLicenses_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt">Licenses, estimated 10 year life</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,500,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--BusinessCombinationRecognizedCustomerRelationships_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt">Customer relationships, estimated 5 year life</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,300,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--Goodwill_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 9pt">Goodwill</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">7,925,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 9pt">Total assets acquired</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">14,209,479</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt">Accounts payable and accrued expenses</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">289,591</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_407_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesRightOfUseLiabilityOperatingLease_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt">Right of use liability – operating lease</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">673,425</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_402_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayable_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt">Notes payable</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,825,101</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_409_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedParty_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 9pt">Notes payable – related party</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">105,539</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total Liabilities Assumed</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">2,893,656</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>
CY2020Q4	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	177000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	395308	usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	62500	usd
	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	25000000	shares
CY2021Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	440000	usd
CY2021Q2	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2022-06-11
CY2021Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.004
CY2021Q4	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	10475053	shares
CY2021Q4	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	24774	usd
	cbgl	Fair Value Of Embedded Derivatives FairValueOfEmbeddedDerivatives	2160048	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	2.42	pure
CY2022Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	2160048	usd
CY2021Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	4747614	usd
CY2022Q1	cbgl	Deferred Financing Costs DeferredFinancingCosts	25200	usd
	cbgl	Changes In Fair Value Of Derivatives ChangesInFairValueOfDerivatives	3634274	usd
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2022Q1	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.10	pure
CY2021Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	4747614	usd
	cbgl	Transfers In Due To Issuance Of Convertible Promissory Notes TransfersInDueToIssuanceOfConvertiblePromissoryNotes	3505280	usd
	cbgl	Transfers Out Due To Repayments Of Convertible Promissory Notes TransfersOutDueToRepaymentsOfConvertiblePromissoryNotes	-304741	usd
	cbgl	Transfers Out Due To Conversions Of Convertible Promissory Notes TransfersOutDueToConversionsOfConvertiblePromissoryNotes	-2153831	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-3634274	usd
CY2022Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	2160048	usd
CY2022Q2	us-gaap	Lessor Operating Lease Term Of Contract LessorOperatingLeaseTermOfContract	P12Y
	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	3600	usd
	us-gaap	Payments For Rent PaymentsForRent	11000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.10	pure
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	33000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	132000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	132000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	132000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	132000	usd
CY2022Q2	cbgl	Lessee Operating Lease Liability Payments Due Year Six LesseeOperatingLeaseLiabilityPaymentsDueYearSix	132000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	77000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	770000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	188389	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	581611	usd
CY2022Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	33000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	99000	usd
CY2021Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	33000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	44000	usd
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	553142691	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	75000000	shares
CY2022Q1	cbgl	Recognized Loss RecognizedLoss	165000	usd
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2022Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	24804305	shares
CY2022Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	23300000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4000000000	shares
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	51181398	shares
CY2022Q2	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	14710	usd
	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	3326790	shares
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	89374	usd
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	350000	usd
	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	32200	usd

Files In Submission

Name	View Source	Status
0001079973-22-000868-index-headers.html	Edgar Link	pending
0001079973-22-000868-index.html	Edgar Link	pending
0001079973-22-000868.txt	Edgar Link	pending
0001079973-22-000868-xbrl.zip	Edgar Link	pending
cbgl-20220531.xsd	Edgar Link	pending
cbgl-20220531_cal.xml	Edgar Link	unprocessable
cbgl-20220531_def.xml	Edgar Link	unprocessable
cbgl-20220531_lab.xml	Edgar Link	unprocessable
cbgl-20220531_pre.xml	Edgar Link	unprocessable
cbgl_10q-053122.htm	Edgar Link	pending
cbgl_10q-053122_htm.xml	Edgar Link	completed
ex31x1.htm	Edgar Link	pending
ex31x2.htm	Edgar Link	pending
ex32x1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CBGL
CANNABIS GLOBAL, INC. Stock $cbgl

2022 Q3 Form 10-Q Financial Statement

#000107997322000868 Filed on July 20, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBGL CANNABIS GLOBAL, INC. Stock $cbgl

2022 Q3 Form 10-Q Financial Statement

#000107997322000868 Filed on July 20, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBGL
CANNABIS GLOBAL, INC. Stock $cbgl